Pharmaceutical Industry

Lannacher has Delivery Problems with Iodine Tablets

The Austrian pharmaceutical company manufactures the only potassium iodide tablets in the German-speaking area. Demand strongly exceeds production capacity.

March 18, 2011

Opportunities for Austrian Medical Technology in the UK

An Austrian study showed Austrian buinesses the opportunities offered by the British market: Austrian exports increased by 15% in 2010.

March 17, 2011

Massive Losses for Intercell

The Austrian pharmaceutical company today reported losses for 2010 amounting to € 255m. Operating cash flow has been strongly negative too.

March 2, 2011

Intercell Issues Convertible Bond

The Austrian pharmaceutical company Intercell starts offering of € 30.8m senior convertible debt financing.

February 23, 2011

Sanochemia: Strong Increase in EBIT

The Austrian pharmaceutical company today announced its figures for Q1. Earnings rise eight-fold.

February 18, 2011

Sanochemia Stays in the Red

Despite improvements in its financial data, the Austrian pharmaceutical company Sanochemia does not succeed in eliminating its losses

January 28, 2011

Sanochemia Takes Over Alvetra & Werfft

The Austrian pharmaceutical company Sanochemia strengthens its market position through the acquisition of Alvetra & Werfft GmbH.

January 25, 2011

Pfizer Austria: First Sustainability Report Published

Pfizer Austria published its first sustainability report based on the recognized guidelines of the Global Reporting Initiative.

January 20, 2011

Sanochemia: Decrease in Sales, Decrease in Losses

The Vienna Stock Exchange listed manufacturer of pharmaceutical products could improve its results slighty.

January 3, 2011

Intercell Raises Authorized Capital

The Management Board of the Austrian biotechnology company is authorized to increase the share capital up to a nominal amount of € 855,000.00.

December 16, 2010

Serious setback for Intercell

The Vienna vaccine manufacturers has to terminate a research project unexpectedly at a late stage. Heavy losses are expected for this year.

December 14, 2010

Economic Chamber in Tokyo: Biotechnology as an Opportunity

The President of the Vienna Economic Chamber, Brigitte Jank, sees above all great opportunities for Austria in Japanese biotechnology and pharmaceutical industries.

December 6, 2010

Trade Between Russia and Austria is Booming

The volume of trade between Austria and Russia has increased by 30%. Innovation and modernization are core issues for both countries.

December 6, 2010

Expansion Potential of Austrian Pharmaceutical Industry in Japan

Japanese pharmaceutical companies need new products and international cooperation. An opportunity for local companies.

December 1, 2010

F-Star Acquired Major Order

The Vienna-located f-star and Boehringer Ingelheim to collaborate in discovery and development of therapeutic antibodies.

November 23, 2010

Roche Lays Off 400 Jobs in Styria

The Swiss pharmaceutical group reduces its international workforce by 6%: a setback for the region.

November 18, 2010

Intercell AG: Losses Doubled, Positive Outlook

Today, Vienna-based Intercell AG announced its financial results for the third quarter of 2010 and presented changes to the Management Board.

November 9, 2010